Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression

BACKGROUND: Patients diagnosed with metastatic breast cancer have poor outcome with a median survival of approximately 2 years. While novel therapeutic options are urgently needed, the great majority of breast cancer research has focused on the primary tumor and less is known about metastatic breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenström, Jenny, Hedenfalk, Ingrid, Hagerling, Catharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893927/
https://www.ncbi.nlm.nih.gov/pubmed/33602289
http://dx.doi.org/10.1186/s13058-021-01403-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893927/
https://www.ncbi.nlm.nih.gov/pubmed/33602289
http://dx.doi.org/10.1186/s13058-021-01403-0

Ejemplares similares